Skip to main content

Advertisement

SpringerLink
Log in

Manifestations of transthyretin-related familial amyloidotic polyneuropathy: Long-term follow-up of Japanese patients after liver transplantation

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

To observe which symptoms of transthyretinrelated familial amyloidotic polyneuropathy (FAP) progressed in the long term after liver transplantation (LT), focusing on cardiac, kidney, and ocular symptoms.

Methods

We reviewed the medical records of 34 Japanese patients with FAP, who underwent LT between 1994 and 2006. The mean follow-up period (±SD) after LT was 9.6 ± 3.4 years. Of the 34 patients, 30 had FAP amyloidogenic transthyretin (ATTR) Val30Met, 1 had FAP ATTR Ser50Ile, and 3 had FAP ATTR Tyr114Cys.

Results

The 10-year survival rates from the onset of FAP and from the time of LT were 100% and 91.4%, respectively. Progression of ocular amyloidosis was seen in 17 (50%) patients, 13 of whom had de novo amyloid deposits in the vitreous body; progression of cardiac amyloidosis was seen in 10 (29%) patients, 4 of whom had newly granular sparkling echo on echocardiography, and 9 of whom had newly implanted pacemakers or implantable cardioverter-defibrillators. Although the mean serum creatinine levels did not increase significantly after LT in any of the patients, the estimated glomerular filtration rate had decreased significantly by 7 years after LT.

Conclusion

Although LT is life-saving for patients with FAP, we observed progression of the ocular and cardiac symptoms of FAP in a significant number of these patients over the long term after LT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Saraiva MJ, Costa PP, Birken S, Goodman DS. Presence of an abdominal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy. Trans Assoc Am Physicians 1983;96:261–270.

    PubMed  CAS  Google Scholar 

  2. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005;62:1057–1062.

    Article  PubMed  Google Scholar 

  3. Ando Y, Suhr OB. Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid 1998;5:288–300.

    Article  PubMed  CAS  Google Scholar 

  4. Ando Y, Araki S, Ando M. Transthyretin and familial amyloidotic polyneuropathy. Intern Med 1993;32:920–922.

    Article  PubMed  CAS  Google Scholar 

  5. Ando E, Ando Y, Okamura R, Uchino M, Ando M, Negi A. Ocular manifestations of familial amyloidotic polyneuropathy type I: long term follow up. Br J Ophthalmol 1997;81:295–298.

    Article  PubMed  CAS  Google Scholar 

  6. Araki S. Type I familial amyloidotic polyneuropathy (Japanese type). Brain Dev 1984;6:128–133.

    PubMed  CAS  Google Scholar 

  7. Connors LH, Richardson AM, Théberge R, Costello CE. Tabulation of transthyretin (TTR) variants as of 1/1/2000. Amyloid 2000;7:54–69.

    Article  PubMed  CAS  Google Scholar 

  8. Makover A, Moriwaki H, Ramakrishnan R, Saraiva MJM, Blaner WS, Goodman DS. Plasma transthyretin. Tissue sites of degradation and turnover in the rat. J Biol Chem 1988;263:8598–8603.

    PubMed  CAS  Google Scholar 

  9. Ando Y, Tanaka Y, Nakazato M, Ericzon BG, Yamashita T, Tashima K, et al. Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation. Biochem Biophys Res Commun 1995;211:354–358.

    Article  PubMed  CAS  Google Scholar 

  10. Suhr OB, Holmgren G, Steen L Wikström L, Norden G, Friman S, et al. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995;60:933–938.

    PubMed  CAS  Google Scholar 

  11. Parrila P, Ramirez P, Andereu LF, Bueno SF, Robles R, Miras M, et al. Long-term results of liver transplantation in familial amyloidotic polyneuropathy type I. Transplantation 1997;64:646–649.

    Article  Google Scholar 

  12. Yamamoto S, Wilczek HE, Nowak G, Larsson M, Oksanen A, Iwata T, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): A single-center experience over 16 years. Am J Transplant 2007;7:2597–2604.

    Article  PubMed  CAS  Google Scholar 

  13. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, et al. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: Implications for amyloid fibrillogenesis. Transplantation 1998;66:229–233.

    Article  PubMed  CAS  Google Scholar 

  14. Hörnsten R, Wiklund U, Olofsson BO, Jensen SM, Suhr OB. Liver transplantation does not prevent the development of lifethreatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation 2004;78:112–116.

    Article  PubMed  Google Scholar 

  15. Okamoto S, Yamashita T, Ando Y, Ueda M, Misumi Y, Obayashi K, et al. Evaluation of myocardial changes in familial amyloid polyneuropathy after liver transplantation. Intern Med 2008;47:2133–2137.

    Article  PubMed  Google Scholar 

  16. Yazaki M, Mitsuhashi S, Tokuda T, Kametani F, Takei YI, Koyama J, et al. Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients. Am J Transplant 2007;7:235–242.

    Article  PubMed  CAS  Google Scholar 

  17. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk RH. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997;64:74–80.

    Article  PubMed  CAS  Google Scholar 

  18. Olofsson BO, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002;73:745–751.

    Article  PubMed  Google Scholar 

  19. Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, et al. A different amyloid formation mechanism: De novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 2004;77:345–349.

    Article  PubMed  CAS  Google Scholar 

  20. Sandgren O, Kjellgren D, Suhr OB. Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy. Acta Ophthalmol 2008;86:520–524.

    Article  PubMed  Google Scholar 

  21. Hara R, Kawaji T, Ando E, Ohya Y, Ando Y, Tanihara H. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients. Arch Ophthalmol 2010;128:206–210.

    Article  PubMed  Google Scholar 

  22. Suhr OB, Ericzon BG, Friman S. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl 2002;8:787–794.

    Article  PubMed  Google Scholar 

  23. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982–992.

    Article  PubMed  CAS  Google Scholar 

  24. Sakashita N, Ando Y, Haraoka K, Terazaki H, Yamashita T, Nakamura M, et al. Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy. Pathol Int 2006;56:408–412.

    Article  PubMed  Google Scholar 

  25. Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994;235:479–485.

    Article  PubMed  CAS  Google Scholar 

  26. Monteiro E, Freire A, Barroso E. Familial amyloid polyneuropathy and liver transplantation. J Hepatol 2004;41:188–194.

    Article  PubMed  Google Scholar 

  27. Okamoto S, Wixner J, Obayashi K, Ando Y, Ericzon BG, Friman S, et al. Liver transplantation for familial amyloidotic polyneuropathy: impact on Swedish patients’ survival. Liver Transpl 2009;15:1229–1235.

    Article  PubMed  Google Scholar 

  28. Westermark P, Sletten K, Johansson B, Cornwell GG 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 1990;87:2843–2845.

    Article  PubMed  CAS  Google Scholar 

  29. Cavallaro T, Martone RL, Dwork AJ, Schon EA, Herbert J. The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Invest Ophthalmol Vis Sci 1990;31:497–501.

    PubMed  CAS  Google Scholar 

  30. Snanoudj R, Durrbach A, Gauthier E, Adams D, Samuel D, Ferlicot S, et al. Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation. Nephrol Dial Transplant 2004;19:1779–1785.

    Article  PubMed  Google Scholar 

  31. Nowak G, Suhr OB, Wikström L, Wilczek H, Ericzon B. The long-term impact of liver transplantation on kidney function in familial amyloidotic polyneuropathy patients. Transpl Int 2005;18:111–115.

    Article  PubMed  Google Scholar 

  32. Carvalho MJ, Lobato L, Ventura A, Beirão I, Rocha G, Seca R, et al. Remission of proteinuria following liver transplantation for familial amyloid polyneuropathy TTR met30. Transplant Proc 2000;32:2664–2666.

    Article  PubMed  CAS  Google Scholar 

  33. Fisher NC, Nightingale PG, Gunson BK, Lipkin GW, Neuberger JM. Chronic renal failure following liver transplantation: A retrospective analysis. Transplantation 1992;66:59–66.

    Article  Google Scholar 

  34. Schmitz V, Laudi S, Moeckel F, Puhl G, Stockmann M, Tran ZV, et al. Chronic renal dysfunction following liver transplantation. Clin Transplant 2008;22:333–340.

    Article  PubMed  Google Scholar 

  35. Yoshimura N, Okajima H, Ushigome H, Sakamoto S, Fujiki M, Okamoto M. Current status of organ transplantation in Japan and worldwide. Surg Today 2010;40:514–525.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Transplantation and Pediatric Surgery, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan

    Yuki Ohya, Katsuhiro Asonuma & Yukihiro Inomata

  2. Department of Diagnostic Medicine, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan

    Yuki Ohya, Masayoshi Tasaki, Mitsuharu Ueda, Hirofumi Jono, Konen Obayashi & Yukio Ando

  3. Department of Neurology, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan

    Sadahisa Okamoto

  4. Department of Ophthalmology and Visual Science, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan

    Ryuhei Hara & Hidenobu Tanihara

  5. Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan

    Kazuhisa Takeda

  6. Department of Transplantation and Regenerative Surgery, Kyoto Prefectural University Graduate School of Medical Science, Kyoto, Japan

    Hideaki Okajima

Authors
  1. Yuki Ohya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sadahisa Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masayoshi Tasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mitsuharu Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hirofumi Jono
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Konen Obayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazuhisa Takeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hideaki Okajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Katsuhiro Asonuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ryuhei Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hidenobu Tanihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yukio Ando
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yukihiro Inomata
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohya, Y., Okamoto, S., Tasaki, M. et al. Manifestations of transthyretin-related familial amyloidotic polyneuropathy: Long-term follow-up of Japanese patients after liver transplantation. Surg Today 41, 1211–1218 (2011). https://doi.org/10.1007/s00595-010-4488-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-010-4488-5

Key words

Search

Navigation